Steroid induced ocular hypertension and glaucoma

Common (1% to 10%): Sinusitis, nasopharyngitis, upper respiratory tract infection, bronchitis
Uncommon (% to 1%): Cough, dyspnea, snoring, dysphonia
Rare (less than %): Pulmonary microembolism (POME) (cough, dyspnea, malaise, hyperhidrosis, chest pain, dizziness, paresthesia, or syncope) caused by oily solutions
Frequency not reported: Sleep apnea
Postmarketing reports: Chest pain, asthma, chronic obstructive pulmonary disease, hyperventilation, obstructive airway disorder, pharyngeal edema, pharyngolaryngeal pain, pulmonary embolism, respiratory distress, rhinitis, sleep apnea syndrome [ Ref ]

Cyclophosphamide is first line in patients with severe disease or rapid progression. 12, 17, 22, 26 It should be started in conjunction with steroids and can be dosed orally or IV. 12, 17, 22, 26 A short course of pulsed IV therapy (ex. 3 days) can be particularly effective in achieving rapid control if needed, such as prior to surgery. 22 The SITE trial found that cyclophosphamide was effective in controlling inflammation in % of patients with OCP at 1 year, with % of patients on less than or equal to 10mg of prednisone. 27 Systemic complications include myelosuppression, carcinogenesis, and teratogenicity. 22, 27

Steroid induced ocular hypertension and glaucoma

steroid induced ocular hypertension and glaucoma

Media:

steroid induced ocular hypertension and glaucomasteroid induced ocular hypertension and glaucomasteroid induced ocular hypertension and glaucomasteroid induced ocular hypertension and glaucomasteroid induced ocular hypertension and glaucoma

http://buy-steroids.org